title: Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia?
authors.affiliation: Hematology-Oncology Unit, Bnai-Zion Medical Center, Haifa, Israel. Tamar.tadmor@b-zion.org.il
authors.forename: Tamar
authors.initials: T
authors.lastname: Tadmor
authors.forename: Aaron
authors.initials: A
authors.lastname: Polliack
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D011961:Receptors, Fc / Q000627:therapeutic use; D053628:Receptors, Thrombopoietin / Q000037:antagonists & inhibitors; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D013926:Thrombopoietin / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim